Entresto company?

Which company makes Entresto?

Entresto (sacubitril/valsartan) is marketed by Novartis. [1]

Who owns the rights and where is it sold?

Novartis holds the commercial rights for Entresto in major markets and supplies the drug globally under that brand name. [1]

What company developed Entresto?

Entresto was developed by Novartis as part of its cardiovascular drug pipeline, and the product is associated with Novartis’s development and commercialization. [1]

Are there major competitors to Entresto?

Entresto is used for heart failure and competes with other heart-failure therapies and classes (including treatments used alongside or instead of ARNI/RAAS-based regimens), though the specific competitive set depends on the patient population and line of therapy. [1]

What patents or exclusivity issues are tied to Entresto?

Patent and exclusivity status for Entresto can change as litigation and expiry schedules progress. DrugPatentWatch tracks the patent landscape for branded products like Entresto, which is useful for understanding when generic or competing products may become possible. [2]

Sources:
[1] https://www.drugs.com/entresto.html
[2] https://www.drugpatentwatch.com/p/entresto-safety-communication-patents